Heritable Collagen Disorders: The Paradigm of the Ehlers—Danlos Syndrome

Journal of Investigative Dermatology

Volumn 132, Issue , 2012, Pages E6-E11

  Byers, Peter H ^a,b   Murray, Mitzi L ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN;

CLASSIFICATION; EHLERS DANLOS SYNDROME; GENETICS; HUMAN; JOINT INSTABILITY; PATHOLOGY; REVIEW; SKIN;

COLLAGEN; EHLERS-DANLOS SYNDROME; HUMANS; JOINT INSTABILITY; SKIN;

EID: 84883053015     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/skinbio.2012.3     Document Type: Article

References (63)

1. Alanay, Y., Avaygan, H., Camacho, N., et al. Mutations in the gene encoding the RER protein FKBP65 cause autosomal-recessive osteogenesis imperfecta. Am J Hum Genet 86 (2010), 551–559.
2. Barabas, A.P., Heterogeneity of the Ehlers-Danlos syndrome: description of three clinical types and a hypothesis to explain the basic defect(s). Br Med J 2 (1967), 612–613.
3. Baumann, M., Giunta, C., Krabichler, B., et al. Mutations in FKBP14 cause a variant of Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss. Am J Hum Genet 90 (2012), 201–216.
4. Beighton, P., De Paepe, A., Steinmann, B., et al. Ehlers-Danlos syndromes: revised nosology, Villefranche, 1997. Ehlers-Danlos National Foundation (USA) and Ehlers-Danlos Support Group (UK). Am J Med Genet 77 (1998), 31–37.
5. Beighton, P., Price, A., Lord, J., et al. Variants of the Ehlers-Danlos syndrome. Clinical, biochemical, haematological, and chromosomal features of 100 patients. Ann Rheum Dis 28 (1969), 228–245.
6. Burch, G.H., Gong, Y., Liu, W., et al. Tenascin-X deficiency is associated with Ehlers-Danlos syndrome. Nat Genet 17 (1997), 104–108.
7. Burrows, N.P., Nicholls, A.C., Yates, J.R., et al. The gene encoding collagen alpha1(V)(COL5A1) is linked to mixed Ehlers-Danlos syndrome type I/II. J Invest Dermatol 106 (1996), 1273–1276.
8. Byers, P.H., Duvic, M., Atkinson, M., et al. Ehlers-Danlos syndrome type VIIA and VIIB result from splice-junction mutations or genomic deletions that involve exon 6 in the COL1A1 and COL1A2 genes of type I collagen. Am J Med Genet 72 (1997), 94–105.
9. Colige, A., Nuytinck, L., Hausser, I., et al. Novel types of mutation responsible for the dermatosparactic type of Ehlers-Danlos syndrome (Type VIIC) and common polymorphisms in the ADAMTS2 gene. J Invest Dermatol 123 (2004), 656–663.
10. Colige, A., Sieron, A.L., Li, S.W., et al. Human Ehlers-Danlos syndrome type VII C and bovine dermatosparaxis are caused by mutations in the procollagen I N-proteinase gene. Am J Hum Genet 65 (1999), 308–317.
11. Danlos, M., Un cas de cutis laxa avec tumeurs par contusion chronique des coudes et des genoux (xanthome juvénile pseudo-diabé-tique de MM Hallopeau et Macé de Lépinay). Bull Soc Franc Dermatol Syph 19 (1908), 70–72.
12. Ehlers, E., Cutis laxa, neigung zu haemorrhagien in der haut, lockerung meherer artikulationen. Dermatol Z 8 (1901), 173–174.
13. Faiyaz-Ul-Haque, M., Zaidi, S.H., Al-Ali, M., et al. A novel missense mutation in the galactosyltransferase-I (B4GALT7) gene in a family exhibiting facioskeletal anomalies and Ehlers-Danlos syndrome resembling the progeroid type. Am J Med Genet A 128A (2004), 39–45.
14. Fukada, T., Civic, N., Furuichi, T., et al. The zinc transporter SLC39A13/ZIP13 is required for connective tissue development; its involvement in BMP/TGF-beta signaling pathways. PLoS One, 3, 2008, e3642.
15. Giunta, C., Elçioglu, N.H., Albrecht, B., et al. Spondylocheiro dysplastic form of the Ehlers-Danlos syndrome—an autosomal-recessive entity caused by mutations in the zinc transporter gene SLC39A13. Am J Hum Genet 82 (2008), 1290–1305.
16. Götte, M., Kresse, H., Defective glycosaminoglycan substitution of decorin in a patient with progeroid syndrome is a direct consequence of two point mutations in the galactosyltransferase I (beta4GalT-7) gene. Biochem Genet 43 (2005), 65–77.
17. Heikkinen, J., Toppinen, T., Yeowell, H., et al. Duplication of seven exons in the lysyl hydroxylase gene is associated with longer forms of a repetitive sequence within the gene and is a common cause for the type VI variant of Ehlers-Danlos syndrome. Am J Hum Genet 60 (1997), 48–56.
18. Hernández, A., Aguirre-Negrete, M.G., González-Flores, S., et al. Ehlers-Danlos features with progeroid facies and mild mental retardation. Further delineation of the syndrome. Clin Genet 30 (1986), 456–461.
19. Holbrook, K.A., Byers, P.H., Ultrastructural characteristics of the skin in a form of the Ehlers-Danlos syndrome type IV storage in the rough endoplasmic reticulum. Lab Invest 44 (1981), 342–350.
20. Julkunen, H., Rokkanen, P., Inoue, H., Scanning electron microscopic study of the collagen bundles of the skin in the Ehlers-Danlos syndrome. Ann Med Exp Biol Fenn 48 (1970), 201–204.
21. Krane, S.M., Pinnell, S.R., Erbe, R.W., Lysyl-protocollagen hydroxylase deficiency in fibroblasts from siblings with hydroxylysine-deficient collagen. Proc Natl Acad Sci USA 69 (1972), 2899–2903.
22. Leistritz, D.F., Pepin, M.G., Schwarze, U., et al. COL3A1 haploinsufficiency results in a variety of Ehlers-Danlos syndrome type IV with delayed onset of complications and longer life expectancy. Genet Med 13 (2011), 717–722.
23. Lenaers, A., Ansay, M., Nusgens, B.V., et al. Collagen made of extended -chains, procollagen, in genetically-defective dermatosparaxic calves. Eur J Biochem 23 (1971), 533–543.
24. Lichtenstein, J.R., Martin, G.R., Kohn, L.D., et al. Defect in conversion of procollagen to collagen in a form of Ehlers-Danlos syndrome. Science 182 (1973), 298–300.
25. Malfait, F., Coucke, P., Symoens, S., et al. The molecular basis of classic Ehlers-Danlos syndrome: a comprehensive study of biochemical and molecular findings in 48 unrelated patients. Hum Mutat 25 (2005), 28–37.
26. Malfait, F., Symoens, S., Coucke, P., et al. Total absence of the alpha2(I) chain of collagen type I causes a rare form of Ehlers-Danlos syndrome with hypermobility and propensity to cardiac valvular problems. J Med Genet, 43, 2006, e36.
27. Malfait, F., Symoens, S., De Backer, J., et al. Three arginine to cysteine substitutions in the pro-alpha (I)-collagen chain cause Ehlers-Danlos syndrome with a propensity to arterial rupture in early adulthood. Hum Mutat 28 (2007), 387–395.
28. Malfait, F., Syx, D., Vlummens, P., et al. Musculocontractural Ehlers-Danlos Syndrome (former EDS type VIB) and adducted thumb clubfoot syndrome (ATCS) represent a single clinical entity caused by mutations in the dermatan-4-sulfotransferase 1 encoding CHST14 gene. Hum Mutat 31 (2010), 1233–1239.
29. McKusick, V.A., Heritable disorders of connective tissue. IV. The Ehlers-Danlos syndrome. J Chronic Dis 3 (1956), 2–24.
30. Miyake, N., Kosho, T., Mizumoto, S., et al. Loss-of-function mutations of CHST14 in a new type of Ehlers-Danlos syndrome. Hum Mutat 31 (2010), 966–974.
31. Nicholls, A.C., Oliver, J.E., McCarron, S., et al. An exon skipping mutation of a type V collagen gene (COL5A1) in Ehlers-Danlos syndrome. J Med Genet 33 (1996), 940–946.
32. Nusgens, B.V., Verellen-Dumoulin, C., Hermanns-Lê, T., et al. Evidence for a relationship between Ehlers-Danlos type VII C in humans and bovine dermatosparaxis. Nat Genet 1 (1992), 214–217.
33. Nuytinck, L., Freund, M., Lagae, L., et al. Classical Ehlers-Danlos syndrome caused by a mutation in type I collagen. Am J Hum Genet 66 (2000), 1398–1402.
34. Okajima, T., Fukumoto, S., Furukawa, K., et al. Molecular basis for the progeroid variant of Ehlers-Danlos syndrome. Identification and characterization of two mutations in galactosyltransferase I gene. J Biol Chem 274 (1999), 28841–28844.
35. Pepin, M., Schwarze, U., Superti-Furga, A., et al. Clinical and genetic features of Ehlers-Danlos syndrome type IV, the vascular type. N Eng J Med 342 (2000), 673–680.
36. Piérard, G.E., Lapière, M., Skin in dermatosparaxis. Dermal microarchitecture and biomechanical properties. J Invest Dermatol 66 (1976), 2–7.
37. Plancke, A., Holder-Espinasse, M., Rigau, V., et al. Homozygosity for a null allele of COL3A1 results in recessive Ehlers-Danlos syndrome. Eur J Hum Genet 17 (2009), 1411–1416.
38. Pope, F.M., Martin, G.R., Lichtenstein, J.R., et al. Patients with Ehlers-Danlos syndrome type IV lack type III collagen. Proc Natl Acad Sci USA 72 (1975), 1314–1316.
39. Pope, F.M., Martin, G.R., McKusick, V.A., Inheritance of Ehlers-Danlos type IV syndrome. J Med Genet 14 (1977), 200–204.
40. Quentin, E., Gladen, A., Rodén, L., et al. A genetic defect in the biosynthesis of dermatan sulfate proteoglycan: galactosyltransferase I deficiency in fibroblasts from a patient with a progeroid syndrome. Proc Natl Acad Sci USA 87 (1990), 1342–1346.
41. Rahman, N., Dunstan, M., Teare, M.D., et al. Ehlers-Danlos syndrome with severe early-onset periodontal disease (EDS-VIII) is a distinct, heterogeneous disorder with one predisposition gene at chromosome 12p13. Am J Hum Genet 73 (2003), 198–204.
42. Schalkwijk, J., Zweers, M.C., Steijlen, P.M., et al. A recessive form of the Ehlers-Danlos syndrome caused by tenascin-X deficiency. N Engl J Med 345 (2001), 1167–1175.
43. Schwarze, U., Atkinson, M., Hoffman, G.G., et al. Null alleles of the COL5A1 gene of type V collagen are a cause of the classical forms of Ehlers-Danlos syndrome (types I and II). Am J Hum Genet 66 (2000), 1757–1765.
44. Schwarze, U., Hata, R., McKusick, V.A., et al. Rare autosomal recessive cardiac valvular form of Ehlers-Danlos syndrome results from mutations in the COL1A2 gene that activate the nonsense-mediated RNA decay pathway. Am J Hum Genet 74 (2004), 917–930.
45. Sheen, V.L., Jansen, A., Chen, M.H., et al. Filamin A mutations cause periventricular heterotopia with Ehlers-Danlos syndrome. Neurology 64 (2005), 254–262.
46. Smith, L.T., Wertelecki, W., Milstone, L.M., et al. Human dermatosparaxis: a form of Ehlers-Danlos syndrome that results from failure to remove the amino-terminal propeptide of type I procollagen. Am J Hum Genet 51 (1992), 235–244.
47. Sokolov, B.P., Prytkov, A.N., Tromp, G., et al. Exclusion of COL1A1, COL1A2, and COL3A1 genes as candidate genes for Ehlers-Danlos syndrome type I in one large family. Hum Genet 88 (1991), 125–129.
48. Steinmann, B., Gitzelmann, R., Vogel, A., et al. Ehlers-Danlos syndrome in two siblings with deficient lysyl hydroxylase activity in cultured skin fibroblasts but only mild hydroxylysine deficit in skin. Helv Paediatr Acta 30 (1975), 255–274.
49. Steinmann, B., Tuderman, L., Peltonen, L., et al. Evidence for a structural mutation of procollagen type I in a patient with the Ehlers-Danlos syndrome type VII. J Biol Chem 255 (1980), 8887–8893.
50. Symoens, S., Syx, D., Malfait, F., et al. Comprehensive molecular analysis demonstrates type V collagen mutations in over 90% of patients with classic EDS and allows to refine diagnostic criteria. Hum Mutat, 2012 (e-pub ahead of print 13 June 2012).
51. Toriello, H.V., Glover, T.W., Takahara, K., et al. A translocation interrupts the COL5A1 gene in a patient with Ehlers-Danlos syndrome and hypomelanosis of Ito. Nat Genet 13 (1996), 361–365.
52. Tschernogobow, A., Ein fall von cutis laxa. Jahresber Ges Med, 27, 1892, 562.
53. Tsipouras, P., Byers, P.H., Schwartz, R.C., et al. Ehlers-Danlos syndrome type IV: cosegregation of the phenotype to a COL3A1 allele of type III procollagen. Hum Genet 74 (1986), 41–46.
54. van Meek'ren Ja (1682) De Dilatabilitate Extra-ordinaria Cutis (observationes medico-chirugicae).
55. Vogel, A., Holbrook, K.A., Steinmann, B., et al. Abnormal collagen fibril structure in the gravis form (type I) of Ehlers-Danlos syndrome. Lab Invest 40 (1979), 201–206.
56. Weber, F.P., Ehlers-Danlos Syndrome. Proc R Soc Med 30 (1936), 30–31.
57. Wechsler, H.L., Fisher, Ehlers-Danlos syndrome. Pathologic, histochemical and electron microscopic observations. Arch Pathol 77 (1964), 613–619.
58. Wenstrup, R.J., Florer, J.B., Brunskill, E.W., et al. Type V collagen controls the initiation of collagen fibril assembly. J Biol Chem 279 (2004), 53331–53337.
59. Wenstrup, R.J., Florer, J.B., Willing, M.C., et al. COL5A1 haploinsufficiency is a common molecular mechanism underlying the classical form of EDS. Am J Hum Genet 66 (2000), 1766–1776.
60. Wenstrup, R.J., Langland, G.T., Willing, M.C., et al. A splice-junction mutation in the region of COL5A1 that codes for the carboxyl propeptide of pro alpha 1(V) chains results in the gravis form of the Ehlers-Danlos syndrome (type I). Hum Mol Genet 5 (1996), 1733–1736.
61. Wordsworth, B.P., Ogilvie, D.J., Sykes, B.C., Segregation analysis of the structural genes of the major fibrillar collagens provides further evidence of molecular heterogeneity in type II Ehlers-Danlos syndrome. Br J Rheumatol 30 (1991), 173–177.
62. Zweers, M.C., Bristow, J., Steijlen, P.M., et al. Haploinsufficiency of TNXB is associated with hypermobility type of Ehlers-Danlos syndrome. Am J Hum Genet 73 (2003), 214–217.
63. Byers, P.H., Murray, M.L., Heritable collagen disorders: the paradigm of the Ehlers—Danlos syndrome. J Invest Dermatol 132 (2012), E6–E11.